Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $25,395,277 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 167 grants at over 100 hospitals in 29 countries.

University of Colorado Denver – $200,000
$200,000.00
November 2023
Preclinical assessment of efficacy and specificity of logic-gated CAR-T cell therapy in Diffuse Intrinsic Pontine Glioma

SIOPe DIPG/DMG Registry – $715,852 USD, € 643,014
$715,852.00
November 2023
Renewal of the European DIPG/DMG Registry

Cincinnati Children's Hospital – $200,000
$200,000.00
November 2023
Targeting diffuse midline gliomas with innovative T cell immunotherapy

Cincinnati Children's Hospital – $50,000
$50,000.00
May 2023
Exploring Novel Targets In DIPG

University Medicine Göttingen – $50,000
$50,000.00
May 2023
Starve the monster: Multi-metabolic treatment strategies for H3.3K27M-mutant DIPG/DMG

Funding of PBTCF 2023 - $25,000
$25,000.00
January 2023

University of Queensland Diamantina Institute – $100,000
$100,000.00
November 2022
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma

Erasmus University Medical Center – $432,354
$432,354.00
November 2022
Development and optimization of targeted radiopharmaceutical therapies for pediatric brain tumors; a world-first translational study. Acronym: TARGET-FIRST

Cincinnati Children's Hospital Medical Center – $60,000
$60,000.00
November 2022
Targeting Histone Lysine Demethylases to Treat Diffuse Intrinsic Pontine Glioma

Cincinnati Children's Hospital Medical Center – $153,867
$153,867.00
November 2022
Combining innovative proton radiotherapy with targeted and immune therapies to treat DMG/DIPG

Hunter Medical Research Institute – $232,932
$232,932.00
November 2022
Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies

SONALASENSE – $198,436
$198,436.00
November 2022
A Phase 1/2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2 in Patients With DIPG

UPMC Childrens Hospital of Pittsburgh – $100,000
$100,000.00
November 2022
The Role of QPRT and NAD Pathways in DIPG Treatment Resistance (Continued)

The Hospital For Sick Children (SickKids) – $100,000
$100,000.00
November 2022
Synthetic lethality screening with methionine restriction for treatment of DIPG

University of Texas MD Anderson Cancer Center – $100,000
$100,000.00
November 2022
Viroimmunotherapy for pediatric brain tumors